Abstract:
:Important differences between explanatory and pragmatic studies were originally argued by Schwartz and Lellouch. Three important differences between the two types of study involve study control, study violators and inclusion criteria. It was originally argued that explanatory studies are highly controlled, and pragmatic studies may be looser and more like 'real life'. It was argued that an explanatory study should only analyse those receiving treatment, and a pragmatic study would analyse all randomized patients. Explanatory trials are said to use homogeneous groups, and pragmatic studies have less selection (better generalizability). Some suggestions are put forward to update the original distinctions between these two attitudes for future study design. Poor study control is undesirable (but might be necessary) and should not be welcomed as pragmatic. The intention-to-treat strategy is now considered as standard for nearly all trials. Homogeneity is a red herring for studies in humans. Inclusion criteria should be minimized and they should not be used to justify claims of representativeness. Routine criticism of randomized controlled trials for being unrepresentative is unwarranted. We should accept that most trials in humans are 'explanatory'. The division line should be moved, so that pragmatic studies are in the domain of non-therapeutics and complex treatments.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
McMahon ADdoi
10.1002/sim.1120subject
Has Abstractpub_date
2002-05-30 00:00:00pages
1365-76issue
10eissn
0277-6715issn
1097-0258journal_volume
21pub_type
杂志文章abstract::Many different methods have been proposed for the analysis of cluster randomized trials (CRTs) over the last 30 years. However, the evaluation of methods on overdispersed count data has been based mostly on the comparison of results using empiric data; i.e. when the true model parameters are not known. In this study, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3681
更新日期:2009-10-30 00:00:00
abstract::In the last decade or so, pharmaceutical drug development activities in the area of new antibacterial drugs for treating serious bacterial diseases have declined, and at the same time, there are worries that the increased prevalence of antibiotic-resistant bacterial infections, especially the increase in drug-resistan...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6233
更新日期:2014-11-10 00:00:00
abstract::In the field of cluster detection, a weighted normal model-based scan statistic was recently developed to analyze regional continuous data and to evaluate the clustering pattern of pre-defined cells (such as state, county, tract, school, hospital) that include many individuals. The continuous measures of interest are,...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3990
更新日期:2010-10-15 00:00:00
abstract::For the analysis of time to event data in contraceptive studies when individuals are subject to competing causes for discontinuation, some authors have recently advocated the use of the cumulative incidence rate as a more appropriate measure to summarize data than the complement of the Kaplan-Meier estimate of discont...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1135
更新日期:2001-12-15 00:00:00
abstract::Geocoding a study population as completely as possible is an important data assimilation component of many spatial epidemiologic studies. Unfortunately, complete geocoding is rare in practice. The failure of a substantial proportion of study subjects' addresses to geocode has consequences for spatial analyses, some of...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3288
更新日期:2008-09-20 00:00:00
abstract::The log-rank test is the most powerful non-parametric test for detecting a proportional hazards alternative and thus is the most commonly used testing procedure for comparing time-to-event distributions between different treatments in clinical trials. When the log-rank test is used for the primary data analysis, the s...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3501
更新日期:2009-02-28 00:00:00
abstract::The FDA permits marketing of a generic formulation of a drug G for the same indications as a standard preparation S if one can show that G is bioequivalent to S. Present implementation requires convincing evidence that the population mean difference in bioavailability (drug exposure) between the two preparations lies ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780111311
更新日期:1992-09-30 00:00:00
abstract::Many models for clinical prediction (prognosis or diagnosis) are published in the medical literature every year but few such models find their way into clinical practice. The reason may be that since in most cases models have not been validated in independent data, they lack generality and/or credibility. In this pape...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1691
更新日期:2004-03-30 00:00:00
abstract::We develop analysis methods for clinical trials with time-to-event outcomes which correct for treatment changes during follow-up, yet are based on comparisons of randomized groups and not of selected groups. A causal model relating observed event times to event times that would have been observed under other treatment...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19991015)18:19<2617::aid-s
更新日期:1999-10-15 00:00:00
abstract::A method is proposed to infer the randomized treatment effect on survival after an adjustment for a post-randomization variable. The post-randomization variable is made independent of the treatment assignment and is considered a surrogate for baseline prognostic factors. The relationship between the post-randomization...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.968
更新日期:2001-11-30 00:00:00
abstract::Combinatorial drugs have been widely applied in disease treatment, especially chemotherapy for cancer, due to its improved efficacy and reduced toxicity compared with individual drugs. The study of combinatorial drugs requires efficient experimental designs and proper follow-up statistical modeling techniques. Linear ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7971
更新日期:2019-01-30 00:00:00
abstract::Many randomized clinical trials include a data and safety monitoring board (DSMB) that is responsible for reviewing accruing data, monitoring performance of the trial, assuring safety of the participants in the trial, and assessing the efficacy of treatment. The DSMB often makes recommendations about continuation of t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780120504
更新日期:1993-03-01 00:00:00
abstract::In the development of a new treatment in oncology, phase II trials play a key role. On the basis of the data obtained during phase II, it is decided whether the treatment should be studied further. Therefore, the decision to be made on the basis of the data of a phase II trial must be as accurate as possible. For ethi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5585
更新日期:2012-12-30 00:00:00
abstract::Mediation analyses can help us to understand the biological mechanism in which an exposure or treatment affects an outcome. Single mediator analyses have been used in various applications, but may not be appropriate for analyzing intricate mechanisms involving multiple mediators that affect each other. Thus, in this a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8485
更新日期:2020-05-15 00:00:00
abstract::Funnel plots are widely used to visualize grouped data, for example, in institutional comparison. This paper extends the concept to a multi-level setting, displaying one level at a time, adjusted for the other levels, as well as for covariates at all levels. These level-adjusted funnel plots are based on a Markov chai...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5677
更新日期:2014-09-20 00:00:00
abstract::In a medical study we are often interested in graphically displaying the relationship between continuous variables and clinical events indicating disease progression. Often, it is reasonable to make the minimal assumption that the risk of progression is an arbitrary monotone function of the continuous variable. Someti...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1561
更新日期:2003-10-30 00:00:00
abstract::A mediator acts as a third variable in the causal pathway between a risk factor and an outcome. In this paper, we consider the estimation of the mediation effect when the mediator is a binary variable. We give a precise definition of the mediation effect and examine asymptotic properties of five different estimators o...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2730
更新日期:2007-08-15 00:00:00
abstract::In this paper we describe Bonferroni-based multiple testing procedures (MTPs) as strategies to split and recycle test mass. Here, 'test mass' refers to (parts of) the nominal level alpha at which the family-wise error rate is controlled. Briefly, test mass is split between different null hypotheses, and whenever a nul...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3513
更新日期:2009-02-28 00:00:00
abstract::This paper considers the regression analysis of CD4 cell counts, a commonly used indicator and prognostic factor of AIDS progression. For this purpose, a number of methods have been proposed and most of them are based on random effects models. We present an alternative that is based on a mean function regression model...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.945
更新日期:2001-11-15 00:00:00
abstract::Often in randomized clinical trials and observational studies in occupational and environmental health, a non-negative continuously distributed response variable denoting some metabolites of environmental toxicants is measured in treatment and control groups. When observations occur in both unexposed and exposed subje...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3170
更新日期:2008-06-15 00:00:00
abstract::Childhood acute lymphoblastic leukaemia is treated with long-term intensive chemotherapy. During the latter part of the treatment, the maintenance therapy, the patients receive oral doses of two cytostatics. The doses are tailored to blood counts measured on a weekly basis, and the treatment is therefore highly dynami...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4393
更新日期:2012-02-28 00:00:00
abstract::Service on the Data Monitoring Committee of the CPEP (Calcium for Pre-eclampsia Prevention) has led us to four conclusions about clinical trials which we should like to present to this gathering of biostatisticians for their reactions: (i) meta-analyses of the pertinent published trials of the same therapy should alwa...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960630)15:12<1263::AID-S
更新日期:1996-06-30 00:00:00
abstract::Statistical methods for analyzing recurrent events have attracted significant attention. The majority of existing works consider situations in which subjects are observed over time periods and events of interest that occurred during the course of follow-up are recorded. In some applications, a subject may leave the st...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8042
更新日期:2019-04-15 00:00:00
abstract::We investigate population-averaged (PA) and cluster-specific (CS) associations for clustered binary logistic regression in the context of a longitudinal clinical trial that investigated the association between tooth-specific visual elastase kit results and periodontal disease progression within 26 weeks of follow-up. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780140407
更新日期:1995-02-28 00:00:00
abstract::When data are dichotomous, this paper notes the utility of inverse sampling in establishing equivalence with respect to the risk ratio. This paper develops an exact equivalence test that accounts for the risk ratio under inverse sampling and further discusses the relationship between the exact equivalence test and the...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19970815)16:15<1777::aid-s
更新日期:1997-08-15 00:00:00
abstract::A trial of Duchenne muscular dystrophy involved tracking boys of all ages through a one-year baseline period, followed by a one-year trial of leucine versus placebo treatment. In this paper we develop a model for a total-muscle-strength score that uses the data of the extended baseline period in the evaluation of the ...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1002/sim.4780050304
更新日期:1986-05-01 00:00:00
abstract::The application of Bayesian hierarchical models to measure spatial effects in time to event data has not been widely reported. This case study aims to estimate the effect of area of residence on waiting times to coronary artery bypass graft (CABG) and to assess the role of important individual specific covariates (age...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1535
更新日期:2003-09-30 00:00:00
abstract::During a course of human immunodeficiency virus (HIV-1) infection, the viral load usually increases sharply to a peak following infection and then drops rapidly to a steady state, where it remains until progression to AIDS. This steady state is often referred to as the viral set point. It is believed that the HIV vira...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3038
更新日期:2008-01-15 00:00:00
abstract::An observed confidence distribution is proposed as a measure of strength of evidence for practically equivalent efficacies of two treatments. The concept is independent of prior opinions about relevant sizes of a difference in efficacy. It also avoids retrospective power calculations for trials with missed recruitment...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780071207
更新日期:1988-12-01 00:00:00
abstract::In many practical applications, count data often exhibit greater or less variability than allowed by the equality of mean and variance, referred to as overdispersion/underdispersion, and there are several reasons that may lead to the overdispersion/underdispersion such as zero inflation and mixture. Moreover, if the c...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5560
更新日期:2013-04-15 00:00:00